Missed Bunzl's Run? What Holders Had To Believe

If Bunzl had been on a watchlist rather than in a portfolio, the share price move this year might look like a painful near miss. Holding Bunzl from the start of the year would have returned 34.3%, including dividends. That jump invites a blunt question. Back on 1 January 2026, what clues in the North American turnaround plan and push into higher margin own-brand products could have helped you treat this as more than just another distributor?

A Narrative on Simply Wall St is one investor's written case for a company, with its growth, margin and multiple assumptions spelled out. Those assumptions imply an estimated Fair Value.

The easy part of this move is behind Bunzl. Zero in on 7 high quality undervalued stocks for companies trading below our estimates.

The Argument You Would Have Been Weighing Up On Bunzl

The shares cost £20.76 at the start of the period, and Bunzl sat between two very different narratives that both sounded plausible.

The bullish case put Fair Value at £26.39, 27% above the start price, and leaned on a recovery in North America plus growth in higher margin own-brand products as a route to better profitability.

The bearish view pinned Fair Value at £19 and focused on accelerating digitalization and sustainability pressures as threats that could erode demand and compress margins over time.

What The Results Changed For The Bunzl Debate

The clearest fresh fact for Bunzl was the H1 2026 report. Total revenue moved from £5,759.6m in H1 2025 to £5,933.1m in H1 2026, while net income increased from £181.9m to £211.3m and net margin edged up from 3.2% to 3.6%. That pattern gave more backing to the optimistic profitability story than to the bearish margin-compression worry.

The useful takeaway is practical. When a story hangs on better profitability rather than just higher sales, focus on whether net income and net margin both improve in the subsequent reports, as they did here, not only on where the top line lands.

What Today's Bunzl Price Already Assumes

Bunzl now trades at £27.1, with this Narrative's Fair Value sitting below that level. The caution does not question whether the business can win new contracts. It questions how much earnings power those wins really lock in once pricing, cost inflation and deal quality are all factored in.

A buyer today effectively assumes Bunzl can keep margins around current guidance while leaning on acquisitions and efficiency projects. The selected Narrative asks how sensitive that outcome is to lower priced new work, regional execution hiccups or acquisition returns that fall short of past deals.

"Key Takeaways: Bearish analysts expect Bunzl to lean even harder on acquisitions to sustain growth, with rising costs and execution issues putting more pressure on margins and making the model more fragile if deal quality or synergies slip. The main factor that needs to go right is that Bunzl continues converting operational efficiency projects, own brand expansion and the North America Distribution reset into stable or better margins, despite cost inflation and initially dilutive new business wins."

Not everyone reads the same price the same way. → See the lower figure this Narrative lands on, and how it gets there

Go Straight To The Source

The story behind this run has already been told. The next one could be taking shape somewhere else. Where could you start looking before it becomes the headline?

• Company 1 - 26% below our estimate - targets everyday supplement use while ramping automated production and distributor-based expansion.
• Company 2 - 36% below our estimate - pursues energy transition mandates that can expand fee-generating infrastructure assets.
• Company 3 - 24% below our estimate - recruits senior lawyers onto a dispersed tech platform operating on shared-fee arrangements.

Those are three of them. See the full list of 9 financially solid companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com